Robert Koch-Institut (RKI)

Investment thesis

The Robert Koch-Institut (RKI) is Germany's central federal agency for disease prevention and control, operating under the Federal Ministry of Health. It does not function as a venture fund or grant agency for commercial startups. Its mandate is public health surveillance, epidemiological research, and regulatory guidance. The strategic agenda focuses on infectious disease monitoring (zoonoses, antimicrobial resistance, pandemic preparedness), non-communicable disease tracking, and health data infrastructure. It funds and operates National Reference Centres and Consular Laboratories to standardise diagnostic testing across Germany. The RKI's role is to generate authoritative public health data and guidelines, not to invest in private sector ventures. Fit verdict: Not a funding source for founders. Founder diligence script: 1. Verify if your project aligns with public health surveillance needs rather than commercial product development. 2. Check if you are eligible for academic or research grants via other German bodies (DFG, BMBF). 3. Confirm if your data or technology can contribute to RKI's open data initiatives or reference lab networks.

Value add

The RKI provides authoritative public health data, epidemiological guidelines, and diagnostic standards. Access to its reference laboratories and surveillance networks offers credibility and technical validation. Collaboration with the RKI can enhance a project's scientific standing in public health. Fit verdict: Not a financial investor. Founder diligence script: 1. Assess if your solution addresses a documented public health gap identified by the RKI. 2. Explore partnerships with RKI-affiliated research institutes for pilot studies. 3. Verify if your technology can integrate with RKI's data infrastructure (e.g., GEDA, surveillance dashboards).

Portfolio focus

The RKI's work clusters around infectious disease surveillance (e.g., SARS-CoV-2 sequencing, Ebola, West Nile virus), non-communicable disease monitoring (e.g., GEDA studies), and antimicrobial resistance tracking. It maintains reference laboratories for zoonoses and viral diseases. The institute publishes the Epidemiological Bulletin and Journal of Health Monitoring to disseminate findings.